Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, HCW Biologics Inc maintains a gross margin of 20.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -20995.92%, while the net margin is -29183.24%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively HCWB converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, HCWB competes directly with industry leaders such as AQB and ELAB. With a market capitalization of $3.80M, it holds a significant position in the sector. When comparing efficiency, HCWB's gross margin of 20.00% stands against AQB's N/A and ELAB's 14.95%. Such benchmarking helps identify whether HCW Biologics Inc is trading at a premium or discount relative to its financial performance.
